Serum Hepcidin Is Associated With Presence of Plaque in Postmenopausal Women of a General Population

Pathways underlying iron accumulation in human nonalcoholic fatty liver disease

(2018) Elmar Aigner et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Associations of common variants inHFEandTMPRSS6with iron parameters are independent of serum hepcidin in a general population: a replication study

(2013) Tessel E Galesloot et al.   JOURNAL OF MEDICAL GENETICS

Hepcidin Destabilizes Atherosclerotic Plaque Via Overactivating Macrophages After Erythrophagocytosis

(2012) Jing Jing Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Hepcidin and iron homeostasis

(2012) Tomas Ganz et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Diurnal Rhythm rather than Dietary Iron Mediates Daily Hepcidin Variations

(2012) C. C. M. Schaap et al.   CLINICAL CHEMISTRY

Iron Overload in Human Disease

(2012) Robert E. Fleming et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study

(2012) Nicola Martinelli et al.   PLoS One

The effect of frequent whole blood donation on ferritin, hepcidin, and subclinical atherosclerosis

(2012) Karlijn Peffer et al.   TRANSFUSION

Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis

(2011) Omar Saeed et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Hepcidin and iron regulation, 10 years later

(2011) T. Ganz   BLOOD

Hepcidin in Human Iron Disorders: Diagnostic Implications

(2011) J. J. C. Kroot et al.   CLINICAL CHEMISTRY

Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations

(2011) M. Traglia et al.   JOURNAL OF MEDICAL GENETICS

Hemoglobin Directs Macrophage Differentiation and Prevents Foam Cell Formation in Human Atherosclerotic Plaques

(2011) Aloke V. Finn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hepcidin as well as TNF-  are significant predictors of arterial stiffness in patients on maintenance hemodialysis

(2011) T. Kuragano et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Hepcidin in β-thalassemia

(2010) Elizabeta Nemeth   Annals of the New York Academy of Sciences

Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations

(2010) Luca Valenti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Two to Tango: Regulation of Mammalian Iron Metabolism

(2010) Matthias W. Hentze et al.   CELL

Biological, clinical and population relevance of 95 loci for blood lipids

(2010) Tanya M. Teslovich et al.   NATURE

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease

(2010) L. Valenti et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: Implications for clinical studies

(2009) Joyce J.C. Kroot et al.   ANALYTICAL BIOCHEMISTRY

Do Hemochromatosis Mutations Protect Against Iron-Mediated Atherogenesis?

(2009) Jerome L. Sullivan   Circulation-Cardiovascular Genetics

Iron in arterial plaque: A modifiable risk factor for atherosclerosis

(2008) Jerome L. Sullivan   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction?

(2008) Dorine W. Swinkels et al.   JOURNAL OF HEPATOLOGY

Blood donation, body iron status and carotid intima-media thickness

(2007) Mariëlle F. Engberink et al.   ATHEROSCLEROSIS